News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,137 Results
Type
Article (87383)
Company Profile (759)
Press Release (771969)
Multimedia
Podcasts (169)
Webinars (27)
Section
Business (233036)
Career Advice (4137)
Deals (39790)
Drug Delivery (134)
Drug Development (91239)
Employer Resources (202)
FDA (18274)
Job Trends (17396)
News (397344)
Policy (39923)
Tag
Academia (3003)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (143)
Alzheimer's disease (1676)
Antibody-drug conjugate (ADC) (223)
Approvals (18286)
Artificial intelligence (480)
Autoimmune disease (68)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (123)
Brain cancer (52)
Breast cancer (474)
Cancer (3782)
Cardiovascular disease (333)
Career advice (3553)
Career pathing (37)
CAR-T (242)
CDC (55)
Cell therapy (672)
Cervical cancer (32)
Clinical research (75264)
Collaboration (1358)
Company closure (4)
Compensation (926)
Complete response letters (59)
COVID-19 (2951)
CRISPR (81)
C-suite (567)
Cystic fibrosis (132)
Data (4222)
Decentralized trials (2)
Denatured (60)
Depression (109)
Diabetes (444)
Diagnostics (7083)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (229)
Drug pricing (186)
Drug shortages (36)
Duchenne muscular dystrophy (199)
Earnings (98742)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132767)
Executive appointments (978)
FDA (20669)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (1226)
Gene editing (173)
Generative AI (46)
Gene therapy (538)
GLP-1 (1012)
Government (5377)
Grass and pollen (7)
Guidances (336)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3183)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (184)
Interviews (815)
IPO (17925)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (636)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (540)
Lymphoma (258)
Machine learning (28)
Management (66)
Manufacturing (628)
MASH (136)
Medical device (14856)
Medtech (14877)
Mergers & acquisitions (22730)
Metabolic disorders (1137)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (224)
Neuropsychiatric disorders (59)
Neuroscience (2692)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (554)
Opinion (310)
Ovarian cancer (123)
Pain (161)
Pancreatic cancer (165)
Parkinson's disease (239)
Partnered (30)
Patents (410)
Patient recruitment (297)
Peanut (57)
People (66214)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23202)
Phase II (32686)
Phase III (24587)
Pipeline (2649)
Policy (292)
Postmarket research (3554)
Preclinical (10479)
Press Release (72)
Prostate cancer (192)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (651)
Real estate (7421)
Recruiting (78)
Regulatory (27928)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (133)
Series A (204)
Series B (150)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (93)
The Weekly (107)
Vaccines (1037)
Venture capital (66)
Weight loss (391)
Women's health (58)
Worklife (21)
Date
Today (27)
Last 7 days (578)
Last 30 days (2276)
Last 365 days (33477)
2025 (25676)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50910)
Australia (8949)
California (9302)
Canada (2822)
China (876)
Colorado (395)
Connecticut (413)
Delaware (258)
Europe (116993)
Florida (1368)
Georgia (311)
Hawaii (3)
Idaho (67)
Illinois (802)
India (49)
Indiana (452)
Iowa (19)
Japan (310)
Kansas (123)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1259)
Massachusetts (6995)
Michigan (307)
Minnesota (558)
Mississippi (4)
Missouri (117)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2568)
New Mexico (32)
New York (2539)
North Carolina (1399)
North Dakota (10)
Northern California (4184)
Ohio (291)
Oklahoma (21)
Oregon (50)
Pennsylvania (1935)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3555)
Tennessee (149)
Texas (1457)
United States (34410)
Utah (275)
Virginia (245)
Washington D.C. (83)
Washington State (802)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,137 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 10, 2025
October 13, 2025
·
1 min read
Press Releases
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
October 13, 2025
·
4 min read
Press Releases
Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 10, 2025
October 13, 2025
·
6 min read
Press Releases
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 10, 2025
October 13, 2025
·
1 min read
Press Releases
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 10, 2025
October 13, 2025
·
3 min read
Press Releases
Third Indication for Kelun-Biotech’s TROP2 ADC Sac-TMT Approved for Marketing by NMPA in EGFRm NSCLC Following Progression on EGFR-TKI Therapy
October 13, 2025
·
8 min read
Press Releases
DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
October 13, 2025
·
13 min read
Press Releases
Nouscom Presents Positive Phase 2 Results of NOUS-209 Immunotherapy Combined with Pembrolizumab in MSI-H Metastatic Colorectal Cancer Patients Refractory to Anti-PD-1 Therapy, at ESMO 2025
October 13, 2025
·
8 min read
Press Releases
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
October 13, 2025
·
6 min read
Press Releases
Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025
October 13, 2025
·
9 min read
1 of 86,014
Next
